CEACAM1 and neoplasm: The interaction between its surface protein CbpF and the N-terminal domain of CEACAM1 primarily activates CEACAM1, inhibiting the IFN-γ secretion response of CD4+ T cells and supporting immune evasion within the tumor microenvironment (Galaski et al., 2021).